1. Draft Guidance on Doxycycline Hyclate. Food and Drug Administration (CDER and CBER). 2022. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/psg/PSG_050751.pdf. Accessed 21 Feb 2024.
2. Tolmar therapeutics I. Atridox® (doxycycline hyclate 10%). Food and Drug Administration (CDER and CBER). 2011. Available at: www.accessdata.fda.gov/drugsatfda_docs/label/2011/050751s015lbl.pdf. Accessed 21 Feb 2024.
3. Malik K, Singh I, Nagpal M, Sandeep A. Atrigel: a potential parenteral controlled drug delivery system. Der Pharmacia Sinica. 2010;1(1):74–81.
4. Wang X, Burgess DJ. Drug release from in situ forming implants and advances in release testing. Adv Drug Deliv Rev. 2021;178: 113912.
5. Oliveira MS, Goulart GCA, Ferreira LAM, Carneiro G. Hydrophobic ion pairing as a strategy to improve drug encapsulation into lipid nanocarriers for the cancer treatment. Expert Opin Drug Deliv. 2017;14(8):983–95.